Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glioblastoma (GBM) is one of the most aggressive tumors and its 5-year survival is approximately 5%. Fluorescence-guided surgery (FGS) improves the extent of resection and leads to better prognosis. Molecular near-infrared (NIR) imaging appears to outperform conventional FGS, however, novel molecula...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Polikarpov, Dmitry M., Campbell, Douglas H., McRobb, Lucinda S., Wu, Jiehua, Lund, Maria E., Lu, Yanling, Deyev, Sergey M., Davidson, Andrew S., Walsh, Bradley J., Zvyagin, Andrei V., Gillatt, David A.
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226459/
https://ncbi.nlm.nih.gov/pubmed/32316186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040984
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items